89 results
Page 2 of 5
8-K
EX-99.1
z7l32oaum7vqpaj2j6fe
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am
8-K
EX-99.1
h4hlz syl1dak4xyrs
13 Nov 23
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
9:12am
8-K
EX-99.1
qotwu01dkwuq
10 Aug 23
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
g42a4xo
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
4r6ze9
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm
8-K
EX-99.1
7tjqvlq k34
30 Mar 23
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
4:15pm
8-K
EX-99.1
aeakkynjhtg
10 Nov 22
Pulse Biosciences Reports Third Quarter 2022 Financial Results
4:20pm
8-K
EX-99.1
qeqfvs0n5wgbsu7asye7
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
8-K
njg cdqsrtoyuu7fjrd
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
424B5
zhho26
4 May 22
Prospectus supplement for primary offering
8:40am
8-K
0dh74yqo96z9 fl
14 Apr 22
Pulse Biosciences, Inc. Announces Rights Offering
4:23pm